Can splenic characteristics predict rectal cancer chemotherapy toxicity and treatment outcomes in rectal cancer patients?

This study has shown that DROSD is an independent predictive factor for reduced DLT in rectal cancer patients undergoing chemotherapy treatment. Further research is needed to validate findings and elucidate underlying mechanisms.

Publication Details

Journal
Oncology
Published
2026-03-24
DOI
https://doi.org/10.1159/000551703
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Can splenic characteristics predict rectal cancer chemotherapy toxicity and treatment outcomes in rectal cancer patients?

Oncology
Inflammatory Biomarkers in Disease Prognosis
article

Can splenic characteristics predict rectal cancer chemotherapy toxicity and treatment outcomes in rectal cancer patients?

article en

Abstract

This study has shown that DROSD is an independent predictive factor for reduced DLT in rectal cancer patients undergoing chemotherapy treatment. Further research is needed to validate findings and elucidate underlying mechanisms.

Oncology
Good health and well-being
Openalex Percentile: Top 9%
Inflammatory Biomarkers in Disease Prognosis
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Can splenic characteristics predict rectal cancer chemotherapy toxicity and treatment outcomes in rectal cancer patients? · Oncology (2026) | TGRS Research Map | TGRS